Advertisement

Child's Nervous System

, Volume 35, Issue 5, pp 889–891 | Cite as

Surgical consideration in Hunter syndrome: a case of hydrocephalus and a case of epidural hematoma

  • Jin Li
  • Xinyan Zhang
  • Raynald
  • Tao Jiang
  • Chunde LiEmail author
Case Report
  • 35 Downloads

Abstract

Introduction

Hunter syndrome (HS) is a rare X-linked lysosomal storage disorder which affects multiple organ systems. Surgical intervention and general anesthesia should be used with caution because of significant airway complications.

Case report

Two HS patients underwent surgery with different prognosis are presented below. In the first case, symptoms of progressive disabilities on motor function, language, intelligence, and development last for 1 year in a 6-year-old boy; magnetic resonance imaging (MRI) showed severe hydrocephalus. Third ventriculostomy was performed in this patient to relieve the hydrocephalus. Unfortunately, this patient died postoperatively due to postsurgical tracheal collapse. In the second case, an 8-year-old girl was referred to our hospital with epidural hematoma because of a falling accident. Trephination surgery was performed under local anesthesia to remove the hematoma. Three days postsurgical, the patient was discharged uneventfully.

Conclusion

General anesthesia in HS patients was associated with poor prognosis due to respiratory complications. Local anesthesia and less intensified treatment should be recommended.

Keywords

Hunter syndrome Surgery Complications Treatment 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. 1.
    Neufeld EU, Muenzer J (2001) The mucopolysaccharidoses. In: The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452Google Scholar
  2. 2.
    Gupta R, Pandey CB, Tripathi S (2014) Mucopolysaccharidosis type II (Hunter’s syndrome) - a clinical case report. Journal of Indian College of Cardiology 5:61–66Google Scholar
  3. 3.
    Ballabio A, Gieselmann V (2009) Lysosomal disorders: from storage to cellular damage. Biochim Biophys Acta 1793:684–696CrossRefGoogle Scholar
  4. 4.
    Scarpa M (2007) Mucopolysaccharidosis Type II. In: R.A. Pagon, T.D. Bird, C.R. Dolan, et al. (eds) GeneReviewsTM [Internet]. (Seattle (WA), USA)Google Scholar
  5. 5.
    Jones SA, Almassy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami R, Tincheva T, Wraith JE, investigators H (2009) Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis 32:534–543CrossRefGoogle Scholar
  6. 6.
    Schwartz GP, Cohen EJ (1998) Hydrocephalus in Maroteaux-Lamy syndrome. Arch Ophthalmol 116:400Google Scholar
  7. 7.
    Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38CrossRefGoogle Scholar
  8. 8.
    Aliabadi H, Reynolds R, Powers CJ, Grant G, Fuchs H, Kurtzberg J (2010) Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery 67:1476–1481 discussion 1481–1472CrossRefGoogle Scholar
  9. 9.
    Kawaguchi T, Fujimura M, Tominaga T (2009) Syringomyelia with obstructive hydrocephalus at the foramens of Luschka and Magendie successfully treated by endoscopic third ventriculostomy. Surg Neurol 71:349–352 discussion 352CrossRefGoogle Scholar
  10. 10.
    Neto AR, Holanda GB, Farias MC, Santos da Costa G, Pereira HS (2013) Hydrocephalus in mucopolysaccharidosis type VI successfully treated with endoscopic third ventriculostomy. J Neurosurg Pediatr 11:327–330CrossRefGoogle Scholar
  11. 11.
    Morehead JM, Parsons DS (1993) Tracheobronchomalacia in Hunter's syndrome. Int J Pediatr Otorhinolaryngol 26:255–261CrossRefGoogle Scholar
  12. 12.
    Nagano R, Takizawa S, Hayama N, Umemura S, Uesugi T, Nakagawa S, Okamoto S, Yanagimachi N, Takagi S (2007) Three-dimensional ct and histopathological findings of airway malacia in hunter syndrome. Tokai J Exp Clin Med 32:59–61Google Scholar
  13. 13.
    Muhlebach MS, Wooten W, Muenzer J (2011) Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev 12:133–138CrossRefGoogle Scholar
  14. 14.
    Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome). Genet Med 8:465–473CrossRefGoogle Scholar
  15. 15.
    Muenzer J, Beck M, Eng C, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E (2009) Multidisciplinary management of Hunter syndrome. Pediatrics 124:1228–1239CrossRefGoogle Scholar
  16. 16.
    Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T (2010) Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II). Mol Genet Metab 99:18–25CrossRefGoogle Scholar
  17. 17.
    Parini R, Rigoldi M, Tedesco L, Boffi L, Brambilla A, Bertoletti S, Boncimino A, Del Longo A, De Lorenzo P, Gaini R, Gallone D, Gasperini S, Giussani C, Grimaldi M, Grioni D, Meregalli P, Messinesi G, Nichelli F, Romagnoli M, Russo P, Sganzerla E, Valsecchi G, Biondi A (2015) Enzymatic replacement therapy for hunter disease: up to 9 years experience with 17 patients. Mol Genet Metab Rep 3:65–74CrossRefGoogle Scholar
  18. 18.
    Mendelsohn NJ, Harmatz P, Bodaner O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R, Investigators HOS (2010) Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey. Genet Med 12:816–822CrossRefGoogle Scholar
  19. 19.
    Quong WL, Kanani M, Elliott MJ (2015) Aorto-Tracheopexy in the treatment of Hunter Syndrome. Ann Thorac Surg 99:2190–2192CrossRefGoogle Scholar
  20. 20.
    Kamin W (2008) Diagnosis and management of respiratory involvement in hunter syndrome. Acta Paediatr 97:57–60CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jin Li
    • 1
  • Xinyan Zhang
    • 2
  • Raynald
    • 3
    • 4
  • Tao Jiang
    • 3
  • Chunde Li
    • 3
    Email author
  1. 1.Department of Anesthesiology, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
  2. 2.Emergency Department, Beijing Haidian Hospital, Beijing Haidian SectionPeking UniversityBeijingChina
  3. 3.Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
  4. 4.Beijing Neurosurgical InstituteCapital Medical UniversityBeijingChina

Personalised recommendations